Michael Brush: This new bull market is just getting started. Buy stocks on weakness.

Bristol-Myers Squibb stock jumps on schizophrenia drug approval

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.

September 27, 2024

Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says

International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the...

September 27, 2024

Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks

The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a...

September 27, 2024

China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in?

China ETFs have surged on the back of a blitz of stimulus measures by the country’s government to revive the...

September 26, 2024

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S....

September 26, 2024

This company had $1 billion in quarterly AI bookings — and it’s not a chip maker

Accenture’s stock rallied toward a six-month high Thursday, after the management consultant got back to beating earnings expectations and continued...

September 26, 2024

Michael Brush: This new bull market is just getting started. Buy stocks on weakness.

About Post Author

Wall Street Today

Other

Business